Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank73
3Y CAGR-16.4%
5Y CAGR+141.0%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
-16.4%/yr
vs +97.3%/yr prior
5Y CAGR
+141.0%/yr
Recent deceleration
Acceleration
-113.7pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
81.2x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$631000.00-6.2%
2025$673000.00-40.6%
2024$1.13M+4.8%
2023$1.08M+939.4%
2022$104000.00+1238.7%
2021$7769.00+106.8%
2020$-114161.00-260.0%
2019$71353.00+113.3%
2018$-537005.00-150.3%
2017$1.07M-